Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
<p>Background: Primaquine is the only licensed drug for eradicating Plasmodium vivax hypnozoites and, therefore, preventing relapses of vivax malaria. It is a vital component of global malaria elimination efforts. Primaquine is efficacious when supervised in clinical trials, but its effective...
Autori principali: | , , , , , , , , , |
---|---|
Altri autori: | |
Natura: | Journal article |
Pubblicazione: |
Public Library of Science
2017
|